Black Diamond Therapeutics, Inc.
BDTXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Black Diamond Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Black Diamond Therapeutics, Inc. — 10-K filed Mar 16, 2026
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 8 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 29, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Prosperity Consulting Group, LLC | 2026-03-31 | 11,355 | Not shown | SEC filing |
| PRUDENTIAL FINANCIAL INC | 2026-03-31 | 17,150 | Not shown | SEC filing |
| Ethic Inc. | 2026-03-31 | 10,695 | Not shown | SEC filing |
| NISA INVESTMENT ADVISORS, LLC | 2026-03-31 | 892 | Not shown | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 1,106,840 | Not shown | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 134,979 | Not shown | SEC filing |
| RB Capital Management, LLC | 2026-03-31 | 35,000 | Not shown | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 4,397 | Not shown | SEC filing |
| CANADA PENSION PLAN INVESTMENT BOARD | 2026-03-31 | 211,400 | Not shown | SEC filing |
| FEDERATED HERMES, INC. | 2026-03-31 | 5,363 | Not shown | SEC filing |
| 683 Capital Management, LLC | 2026-03-31 | 247,958 | Not shown | SEC filing |
| Balyasny Asset Management L.P. | 2026-03-31 | 510,811 | Not shown | SEC filing |
| D. E. Shaw & Co., Inc. | 2026-03-31 | 363,921 | Not shown | SEC filing |
| Bank of New York Mellon Corp | 2026-03-31 | 189,148 | Not shown | SEC filing |
| Federation des caisses Desjardins du Quebec | 2026-03-31 | 280 | Not shown | SEC filing |
| Russell Investments Group, Ltd. | 2026-03-31 | 250 | Not shown | SEC filing |
| NORTHERN TRUST CORP | 2026-03-31 | 464,708 | Not shown | SEC filing |
| China Universal Asset Management Co., Ltd. | 2026-03-31 | 10,111 | Not shown | SEC filing |
| Advisory Services Network, LLC | 2026-03-31 | 67 | Not shown | SEC filing |
- Each value is checked against Black Diamond Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 19 rows: no share price from within three months of their report dates is on file, so they could not be checked.
- 1 row left out: the value per share it reports is far from Black Diamond Therapeutics, Inc.'s share prices on file from around the report date, far from the value most filers reported for that date, or the value of a security already left out, so it may describe another security or share class.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security. Filers with a row left out above, or with no row above to check, are not listed.
- MILLENNIUM MANAGEMENT LLC: 296,556 shares reported 2025-12-31; 134,979 shares reported 2026-03-31.
92 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Black Diamond Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-03-19 · BB BIOTECH AG: Larger than all 32 other insider sales of Common Stock on file. SEC filing
- 2025-03-19 · BB BIOTECH AG: Larger than 30 of the 32 other insider sales of Common Stock on file. SEC filing
- 2025-03-19 · BB BIOTECH AG: Larger than 30 of the 32 other insider sales of Common Stock on file. SEC filing
- 2025-03-19 · BB BIOTECH AG: Larger than 29 of the 32 other insider sales of Common Stock on file. SEC filing
- 2023-06-27 · BB BIOTECH AG: Larger than all 19 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-03-19 | BB BIOTECH AG · 10% owner | Common Stock | S — Open market or private sale | −400,000 | 2.09 | SEC filing |
| 2025-03-19 | BB BIOTECH AG · 10% owner | Common Stock | S — Open market or private sale | −584,292 | 1.95 | SEC filing |
| 2025-03-19 | BB BIOTECH AG · 10% owner | Common Stock | S — Open market or private sale | −1,000,000 | 2.31 | SEC filing |
| 2025-03-19 | BB BIOTECH AG · 10% owner | Common Stock | S — Open market or private sale | −500,000 | 2.12 | SEC filing |
| 2025-03-19 | BB BIOTECH AG · 10% owner | Common Stock | S — Open market or private sale | −300,000 | 1.94 | SEC filing |
| 2025-03-19 | BB BIOTECH AG · 10% owner | Common Stock | S — Open market or private sale | −1,000,000 | 2.07 | SEC filing |
| 2025-03-19 | BB BIOTECH AG · 10% owner | Common Stock | S — Open market or private sale | −2,000,000 | 2.00 | SEC filing |
| 2024-08-28 | Versant Venture Capital VI, L.P. · 10% owner | Common Stock | S — Open market or private sale | −221,600 | 6.32 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-26 | Behbahani Ali · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-06-26 | Kulkarni Samarth · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-06-26 | Menzel Garry E · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-06-26 | Raman Prakash · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-06-26 | Dhingra Kapil · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-06-26 | Campbell Shannon · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-06-19 | Raman Prakash · Director | Common Stock | A — Grant, award, or other acquisition | +7,907 | SEC filing |
| 2026-06-19 | Behbahani Ali · Director | Common Stock | A — Grant, award, or other acquisition | +8,961 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2021-05-20 | Shah Rajeev M. · Director | Common Stock | J — Other acquisition or disposition | −443 | SEC filing |
| 2021-04-01 | Shah Rajeev M. · Director | Common Stock | J — Other acquisition or disposition | +353,814 | SEC filing |
| 2020-12-14 | Bolzon Bradley J PhD · Director, 10% owner | Common Stock | J — Other acquisition or disposition | +11 | SEC filing |
| 2020-12-14 | Versant Venture Capital VI, L.P. · 10% owner | Common Stock | J — Other acquisition or disposition | −20,784 | SEC filing |
| 2020-12-14 | Versant Venture Capital VI, L.P. · 10% owner | Common Stock | J — Other acquisition or disposition | −310 | SEC filing |
| 2020-12-14 | Versant Venture Capital VI, L.P. · 10% owner | Common Stock | J — Other acquisition or disposition | −307 | SEC filing |
| 2020-12-14 | Bolzon Bradley J PhD · Director, 10% owner | Common Stock | J — Other acquisition or disposition | +307 | SEC filing |
| 2020-12-14 | Bolzon Bradley J PhD · Director, 10% owner | Common Stock | J — Other acquisition or disposition | −307 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.